Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Allegri

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|November 10, 2010
Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-upPia Allegri, Antonio Mastromarino, Piergiorgio Neri
Medicina (Kaunas, Lithuania)|July 27, 2022
Sarcoid Uveitis: An Intriguing ChallengerPia Allegri, Sara Olivari, Federico Rissotto, et al.
Journal of Ophthalmic & Vision Research|March 29, 2012
CNS diseases and uveitisPia Allegri, Roberto Rissotto, Carl P Herbort, et al.
European Journal of Ophthalmology|April 4, 2022
Management of presumed candida endophthalmitis during the COVID-19 pandemic: Case report and review of the literatureFederica Fossataro, Francesco Martines, Piergiorgio Neri, et al.
Ocular Immunology and Inflammation|March 30, 2022
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical StudyPia Allegri, Luca Cimino, Janet L Davis, et al.
International Ophthalmology|February 3, 2011
Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmologyPiergiorgio Neri, Manuela Zucchi, Pia Allegri, et al.
Seminars in Ophthalmology|April 16, 2016
Pediatric Conjunctivitis and Air Pollution Exposure: A Prospective Observational StudyPaolo Nucci, Matteo Sacchi, Francesco Pichi, et al.
Investigative Ophthalmology & Visual Science|February 13, 2014
Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edemaPia Allegri, Ugo Murialdo, Simona Peri, et al.
Clinical Drug Investigation|May 6, 2010
Mesalazine-induced multi-organ hypersensitivityBruno Sposato, Maria Pia Allegri, Maria Piera Riccardi, et al.
Allergy|March 20, 2019
Management of ocular allergyAndrea Leonardi, Diana Silva, Daniel Perez Formigo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Ophthalmology (Auckland, N.Z.)|November 10, 2010
Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-upPia Allegri, Antonio Mastromarino, Piergiorgio Neri
Medicina (Kaunas, Lithuania)|July 27, 2022
Sarcoid Uveitis: An Intriguing ChallengerPia Allegri, Sara Olivari, Federico Rissotto, et al.
Journal of Ophthalmic & Vision Research|March 29, 2012
CNS diseases and uveitisPia Allegri, Roberto Rissotto, Carl P Herbort, et al.
European Journal of Ophthalmology|April 4, 2022
Management of presumed candida endophthalmitis during the COVID-19 pandemic: Case report and review of the literatureFederica Fossataro, Francesco Martines, Piergiorgio Neri, et al.
Ocular Immunology and Inflammation|March 30, 2022
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical StudyPia Allegri, Luca Cimino, Janet L Davis, et al.
International Ophthalmology|February 3, 2011
Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmologyPiergiorgio Neri, Manuela Zucchi, Pia Allegri, et al.
Seminars in Ophthalmology|April 16, 2016
Pediatric Conjunctivitis and Air Pollution Exposure: A Prospective Observational StudyPaolo Nucci, Matteo Sacchi, Francesco Pichi, et al.
Investigative Ophthalmology & Visual Science|February 13, 2014
Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edemaPia Allegri, Ugo Murialdo, Simona Peri, et al.
Clinical Drug Investigation|May 6, 2010
Mesalazine-induced multi-organ hypersensitivityBruno Sposato, Maria Pia Allegri, Maria Piera Riccardi, et al.
Allergy|March 20, 2019
Management of ocular allergyAndrea Leonardi, Diana Silva, Daniel Perez Formigo, et al.
Pageof 2